Short-Term Treatment with Proton-Pump Inhibitors as a Test for Gastroesophageal Reflux Disease: A Meta-Analysis of Diagnostic Test Characteristics

Annals of Internal Medicine

Volumn 140, Issue 7, 2004, Pages

  Numans, Mattijs E ^a   Lau, Joseph ^b   De Wit, Niek J ^b   Bonis, Peter A ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESOMEPRAZOLE; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE;

ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DOSE RESPONSE; ENDOSCOPY; GASTROESOPHAGEAL REFLUX; HUMAN; META ANALYSIS; PH MEASUREMENT; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZATION; SENSITIVITY AND SPECIFICITY; STANDARD; STOMACH PH; TREATMENT OUTCOME;

EID: 1842539505     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-140-7-200404060-00011     Document Type: Article

References (47)

1. Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology. 1997;112:1448-56. [PMID: 9136821]
2. van Bommel MJ, Numans ME, de Wit NJ, Stalman WA. Consultations and referrals for dyspepsia in general practice - a one year database survey. Postgrad Med J. 2001;77:514-8. [PMID: 11470932]
3. DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol. 1999;94:1434-42. [PMID: 10364004]
4. Kroes RM, Numans ME, Jones RH, de Wit NJ, Verheij TJ. Gastro-oesophageal reflux disease in primary care. Comparison and evaluation of existing national guidelines and development of uniform European guidelines. European Journal of General Practrice. 1999;5:88-97.
5. van Pinxteren B, Numans ME, Lau J, de Wit NJ, Hungin AP, Bonis PA. Short-term treatment of gastroesophageal reflux disease. J Gen Intern Med. 2003;18:755-63. [PMID: 12950485]
6. Fass R. Empirical trials in treatment of gastroesophageal reflux disease. Dig Dis. 2000;18:20-6. [PMID: 10729734]
7. Schindlbeck NE, Klauser AG, Voderholzer WA, Muller-Lissner SA. Empiric therapy for gastroesophageal reflux disease. Arch Intern Med. 1995;155:1808-12. [PMID: 7654116]
8. Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, Festen HP, Jansen EH, Tuynman HA, et al. Omeprazole as a diagnostic tool in gastroesophageal reflux disease. Am J Gastroenterol. 1997;92:1997-2000. [PMID: 9362179]
9. Juul-Hansen P, Rydning A, Jacobsen CD, Hansen T. High-dose proton-pump inhibitors as a diagnostic test of gastro-oesophageal reflux disease in endoscopic-negative patients. Scand J Gastroenterol. 2001;36:806-10. [PMID: 11495074]
10. Fass R, Ofman JJ, Gralnek IM, Johnson C, Camargo E, Sampliner RE, et al. Clinical and economic assessment of the omeprazole test in patients with symptoms suggestive of gastroesophageal reflux disease. Arch Intern Med. 1999;159:2161-8. [PMID: 10527293]
11. Bate CM, Riley SA, Chapman RW, Durnin AT, Taylor MD. Evaluation of omeprazole as a cost-effective diagnostic test for gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 1999;13:59-66. [PMID: 9892880]
12. An evidence-based appraisal of reflux disease management - the Genval Workshop Report. Gut. 1999;44 Suppl 2:S1-16. [PMID: 10741335]
13. Deville WL, Bezemer PD, Bouter LM. Publications on diagnostic test evaluation in family medicine journals: an optimal search strategy. J Clin Epidemiol. 2000;53:65-9. [PMID: 10693905]
14. Ioannidis JP, Chew P, Lau J. Standardized retrieval of side effects data for meta-analysis of safety outcomes. A feasibility study in acute sinusitis. J Clin Epidemiol. 2002;55:619-26. [PMID: 12063104]
15. Numans ME, de Wit NJ. Reflux symptoms in general practice: diagnostic evaluation of the Carlsson-Dent gastro-oesophageal reflux disease questionnaire. Aliment Pharmacol Ther. 2003;17:1049-55. [PMID: 12694087]
16. Numans ME, Van der Graaf Y, de Wit NJ, Touw-Otten F, de Melker RA. How much ulcer is ulcer-like? Diagnostic determinants of peptic ulcer in open access gastroscopy. Fam Pract. 1994;11:382-8. [PMID: 7895965]
17. Demeester TR, Johnson LF, Joseph GJ, Toscano MS, Hall AW, Skinner DB. Patterns of gastroesophageal reflux in health and disease. Ann Surg. 1976;184:459-70. [PMID: 13747]
18. Mulrow CD, Linn WD, Gaul MK, Pugh JA. Assessing quality of a diagnostic test evaluation. J Gen Intern Med. 1989;4:288-95. [PMID: 2760697]
19. Brun J, Sorngard H. High dose proton pump inhibitor response as an initial strategy for a clinical diagnosis of gastro-oesophageal reflux disease (GERD). Swedish multi-centre group in primary health care. Fam Pract. 2000;17:401-4. [PMID: 11021899]
20. Carlsson R, Dent J, Watts R, Riley S, Sheikh R, Hatlebakk J, et al. Gastrooesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group. Eur J Gastroenterol Hepatol. 1998;10:119-24. [PMID: 9581986]
21. Dupas JL, Houcke P, Samoyeau R, French Collaborative Pantoprazole Study Group. Pantoprazole versus lansoprazole in French patients with reflux esophagitis. Gastroenterol Clin Biol. 2001;25:245-50. [PMID: 11395670]
22. Farup PG, Hovde O, Torp R, Wetterhus S. Patients with functional dyspepsia responding to omeprazole have a characteristic gastro-oesophageal reflux pattern. Scand J Gastroenterol. 1999;34:575-9. [PMID: 10440606]
23. Fass R, Ofman JJ, Sampliner RE, Camargo I, Wendel C, Fennerty MB. The omeprazole test is as sensitive as 24-h oesophageal pH monitoring in diagnosing gastro-oesophageal reflux disease in symptomatic patients with erosive oesophagitis. Aliment Pharmacol Ther. 2000;14:389-96. [PMID: 10759617]
24. Galmiche JP, Barthelemy P, Hamelin B. Treating the symptoms of gastrooesophageal reflux disease: a double-blind comparison of omeprazole and cisapride. Aliment Pharmacol Ther. 1997;11:765-73. [PMID: 9305487]
25. Hatlebakk JG, Hyggen A, Madsen PH, Walle PO, Schulz T, Mowinckel P, et al. Heartburn treatment in primary care: randomised, double blind study for 8 weeks. BMJ. 1999;319:550-3. [PMID: 10463897]
26. Johnsson F, Weywadt L, Solhaug JH, Hernqvist H, Bengtsson L. One-week omeprazole treatment in the diagnosis of gastro-oesophageal reflux disease. Scand J Gastroenterol. 1998;33:15-20. [PMID: 9489902]
27. Lewin van den Broek NT, Numans ME, Buskens E, Verheij TJ, de Wit NJ, Smout AJ. A randomised controlled trial of four management strategies for dyspepsia: relationships between symptom subgroups and strategy outcome. Br J Gen Pract. 2001;51:619-24. [PMID: 11510389]
28. Talley NJ, Meineche-Schmidt V, Pare P, Duckworth M, Raisanen P, Pap A, et al. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther. 1998;12:1055-65. [PMID: 9845395]
29. Venables TL, Newland RD, Patel AC, Hole J, Wilcock C, Turbitt ML. Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice. Scand J Gastroenterol. 1997;32:965-73. [PMID: 9361167]
30. Hatlebakk JG, Berstad A, Carling L, Svedberg LE, Unge P, Ekstrom P, et al. Lansoprazole versus omeprazole in short-term treatment of reflux oesophagitis. Results of a Scandinavian multicentre trial. Scand J Gastroenterol. 1993;28:224-8. [PMID: 8446846]
31. Savary M, Miller G. The Oesophagus. Soluthurn, Switzerland: Grassmann; 1977.
32. Kahrilas PJ, Quigley EM. Clinical esophageal pH recording: a technical review for practice guideline development. Gastroenterology. 1996;110:1982-96. [PMID: 8964428]
33. Weusten BL, Roelofs JM, Akkermans LM, Van Berge-Henegouwen GP, Smout AJ. The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal pH data. Gastroenterology. 1994;107:1741-5. [PMID: 7958686]
34. Johnsson F, Hatlebakk JG, Klintenberg AC, Roman J, Toth E, Stubberöd A, et al. One-week esomeprazole treatment: an effective confirmatory test in patients with suspected gastroesophageal reflux disease. Scand J Gastroenterol. 2003;38:354-9. [PMID: 12739706]
35. Hetzel DJ, Dent J, Reed WD, Narielvala FM, Mackinnon M, McCarthy JH, et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology. 1988;95:903-12. [PMID: 3044912]
36. Ollyo JB, Lang F, Fontolliet C, Monnier P. Savary-Miller's new reproducible, logical, complete and useful classification [Abstract]. Gastroenterology. 1990;98:A100.
37. Orlando RC. Esophageal epithelial defenses against acid injury. Am J Gastroenterol. 1994;89(8 Suppl):S48-52. [PMID: 8048414]
38. Bytzer P, Hansen JM, Schaffalitzky de Muckadell OB, Malchow-Moller A. Predicting endoscopic diagnosis in the dyspeptic patient. The value of predictive score models. Scand J Gastroenterol. 1997;32:118-25. [PMID: 9051871]
39. Moses LE, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med. 1993;12:1293-316. [PMID: 8210827]
40. Littenberg B, Moses LE. Estimating diagnostic accuracy from multiple conflicting reports: a new meta-analytic method. Med Decis Making. 1993;13:313-21. [PMID: 8246704]
41. Swets JA. Measuring the accuracy of diagnostic systems. Science. 1988;240:1285-93. [PMID: 3287615]
42. Shapiro DE. Issues in combining independent estimates of the sensitivity and specificity of a diagnostic test. Acad Radiol. 1995;2 Suppl 1: S37-47; discussion S65-9, S83. [PMID: 9419704]
43. Lau J. Meta-Test, version 0.6. Boston: New England Medical Center; 1997.
44. Bonis PA, Ioannidis JP, Cappelleri JC, Kaplan MM, Lau J. Correlation of biochemical response to interferon alfa with histological improvement in hepatitis C: a meta-analysis of diagnostic test characteristics. Hepatology. 1997;26:1035-44. [PMID: 9328332]
45. van Herwaarden MA, Smout AJ. Diagnosis of reflux disease. Baillieres Best Pract Res Clin Gastroenterol. 2000;14:759-74. [PMID: 11003808]
46. Watson RG, Tham TC, Johnston BT, McDougall NI. Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux-the "sensitive oesophagus". Gut. 1997;40:587-90. [PMID: 9203934]
47. Klauser AG, Schindlbeck NE, Muller-Lissner SA. Symptoms in gastrooesophageal reflux disease. Lancet. 1990;335:205-8. [PMID: 1967675]